Bevacizumab Added to Neoadjuvant Chemotherapy in HER2-Negative Non-Metastatic Breast Cancer

Detalles Bibliográficos
Autores principales: Wan, Guoxing, Cao, Fengjun, Wang, Xuanbin, Sun, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Letter To The Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360292/
https://www.ncbi.nlm.nih.gov/pubmed/30719135
http://dx.doi.org/10.7150/jca.29461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360292/
https://www.ncbi.nlm.nih.gov/pubmed/30719135
http://dx.doi.org/10.7150/jca.29461

Ejemplares similares